Phio Pharmaceuticals Corp. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| CAUWENBERGH GEERT | President & CEO | Purchase | 1,000 | $2.97 | $2,970 | 23,100 | Jun 4, 2014 |
| Advanced RNA Technologies, LLC | — | Other | 5,000 | $4.11 | $20,550 | 1,250,315 | Apr 22, 2014 |
| Advanced RNA Technologies, LLC | — | Other | 2,000 | $6.00 | $12,000 | 1,263,315 | Mar 12, 2014 |
| Advanced RNA Technologies, LLC | — | Other | 2,600 | $6.20 | $16,120 | 1,247,315 | Feb 27, 2014 |
| Advanced RNA Technologies, LLC | — | Other | 5,000 | $6.45 | $32,250 | 1,278,615 | Feb 26, 2014 |
| Advanced RNA Technologies, LLC | — | Other | 5,000 | $4.85 | $24,250 | 1,273,160 | Feb 20, 2014 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 800 | $3.19 | $2,552 | 21,100 | Oct 30, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 1,000 | $3.34 | $3,340 | 20,100 | Oct 23, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 200 | $3.50 | $700 | 18,800 | Oct 18, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.51 | $351 | 18,300 | Oct 14, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 1,000 | $3.15 | $3,150 | 18,100 | Oct 9, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 200 | $3.49 | $698 | 17,100 | Oct 3, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 300 | $3.42 | $1,026 | 16,800 | Sep 30, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 300 | $3.50 | $1,050 | 16,500 | Sep 24, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 174 | $3.49 | $607 | 16,100 | Sep 23, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 326 | $3.52 | $1,148 | 15,926 | Sep 20, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.48 | $348 | 15,600 | Sep 18, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 200 | $3.55 | $710 | 15,400 | Sep 17, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.55 | $355 | 15,100 | Sep 13, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 200 | $3.65 | $730 | 14,700 | Sep 10, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.38 | $338 | 14,300 | Aug 30, 2013 |
| Lockshin Curtis | — | Purchase | 1,000 | $3.70 | $3,700 | 1,000 | Aug 29, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 200 | $3.55 | $710 | 14,200 | Aug 29, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.70 | $370 | 13,800 | Aug 28, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.70 | $370 | 13,400 | Aug 27, 2013 |
| Bitterman Robert J | — | Purchase | 500 | $3.90 | $1,950 | 1,500 | Aug 26, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 200 | $3.69 | $738 | 13,300 | Aug 23, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 300 | $3.62 | $1,086 | 13,000 | Aug 22, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 680 | $3.80 | $2,584 | 12,700 | Aug 21, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 300 | $3.90 | $1,170 | 11,620 | Aug 20, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 100 | $3.86 | $386 | 11,100 | Aug 19, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 500 | $4.00 | $2,000 | 10,500 | Aug 6, 2013 |
| Bitterman Robert J | — | Purchase | 100 | $4.05 | $405 | 1,000 | Aug 5, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 500 | $4.10 | $2,050 | 9,833 | Jul 31, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 167 | $4.02 | $671 | 10,000 | Jul 31, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 500 | $4.54 | $2,270 | 9,333 | Jul 29, 2013 |
| CAUWENBERGH GEERT | President & CEO | Purchase | 500 | $4.87 | $2,435 | 8,833 | Jul 26, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 28,000 | $0.16 | $4,480 | 38,820,446 | Jul 23, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 100,000 | $0.16 | $16,000 | 39,160,130 | Jul 18, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 100,000 | $0.20 | $20,000 | 39,460,130 | Jul 11, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 18,180 | $0.20 | $3,636 | 39,590,130 | Jul 5, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 9,249 | $0.20 | $1,850 | 39,838,310 | Jul 1, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 50,000 | $0.19 | $9,500 | 40,224,933 | Jun 26, 2013 |
| Galena Biopharma, Inc. | — | Sale | 253,000 | $0.19 | $48,070 | 32,393,095 | Apr 30, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 40,000 | $0.30 | $12,000 | 39,791,365 | Mar 20, 2013 |
| CAUWENBERGH GEERT | President & CEO | Award / Grant | 250,000 | $0.15 | $37,500 | 250,000 | Mar 6, 2013 |
| Advanced RNA Technologies, LLC | — | Other | 29,888 | $0.16 | $4,782 | 40,855,378 | Feb 11, 2013 |